ANDHealth+ Program 2026

Australia’s leading digital and connected health accelerator

IMPORTANT NOTE:
Unless otherwise stated, the deadline for submissions is strictly 11:59PM AEST on 28th of September 2026.

ANDHealth+ is a commercialisation acceleration program for innovative digital and connected health technologies with demonstrable commercial and clinical impact potential.

The two-stage program supports proof-of-concept stage, evidence-based digital and connected health SMEs through:
• Up to $5 million non-dilutive project funding, tranched according to agreed milestones
• Significant in-kind support, specialised expertise and hands-on resources
• A global network of industry advisors, investors, clinicians, executives and corporate partners
• Cohort and alumni-only events and opportunities
• With no equity requirements or IP transfer.
Selected participants will work with a dedicated ANDHealth support team and an Industry Advisory Panel to address and overcome key challenges along the commercialisation pathway.

Each intake, up to five companies are selected via a proven and competitive assessment process, driven by a multi-sectoral, multi-disciplinary group of industry leaders with experience in evaluating and selecting high-potential SMEs.

ANDHealth is supported by the Australian Government through the Medical Research Future Fund (MRFF) Medical Research Commercialisation Initiative

There will be three intakes under the MRFF BioMedtech Incubator 2024 funding stream, with applications for the 2026 Cohort open until the end of September.